openPR Logo
Press release

MEDI+SIGN Announces Dr. Anthony Stanowski as New Advisory Board Member

06-20-2017 04:45 PM CET | Health & Medicine

Press release from: MEDI+SIGN

MEDI+SIGN, a healthcare technology company that provides automated communication to the patient’s bedside, would like to officially welcome Anthony Stanowski, DHA, FACHE to the MEDI+SIGN Advisory Board.

“We are eager to work side-by-side with Dr. Stanowski whose insight and expertise in healthcare will provide invaluable direction for the company,” says Andrew Hoffman, President of MEDI+SIGN.

Dr. Stanowski is the President and CEO for the Commission on Accreditation of Healthcare Management Education (CAHME) which advances the quality of graduate healthcare management education through accreditation. He previously held executive and management positions at Fortune 200 companies, such as Aramark and Thomson Reuters Healthcare Division, academic and community based health systems, and small innovative entrepreneurial organizations.

On being named to the advisory board, Dr. Stanowski, a passionate champion of quality improvement and the patient experience, stated: “MEDI+SIGN’s technology is a gateway to improving quality care by providing patients access to information on their caregivers and their treatment plans. Expanding patient access to this technology can accelerate coordination of care and enhancing the patient experience.”

Dr. Stanowski is a frequent conference presenter, and co-authored the book, We Have a Match: My Journey through America’s Transplant System. He has extensive experience serving on healthcare boards; he currently chairs the Board Quality Committee at Bon Secours Baltimore Health System. He served on the American Hospital Association Committee on Governance, as President of Healthcare Planning and Marketing Society of New Jersey and as the inaugural president of the Widener University Healthcare Management Alumni Association.

Dr. Stanowski received his doctorate degree from the Medical University of South Carolina and holds graduate degrees from Drexel (Marketing) and Widener (Health Care Administration) as well as a bachelor’s degree from the University of Pennsylvania (Communications and Psychology). He is Board Certified in healthcare management as a Fellow in the American College of Healthcare Executives.

For more information, contact MEDI+SIGN at our website: www.medisigndisplays.com, or by phone (301-790-0103).

MEDI+SIGN provides hospital and healthcare organizations with a connected health platform that includes patient monitoring and digital whiteboard display solutions. MEDI+SIGN is an integrator of electronic health records and remote monitoring systems to collect and communicate updated and accurate patient health and status information to care teams and patients. MEDI+SIGN was established to leverage its proprietary visual communication technology to improve hospital and healthcare provider’s performance in patient safety and satisfaction, as well as the overall quality and delivery of healthcare.

MEDI+SIGN, division of Noventri
20940 Twin Springs Drive
Smithsburg, MD 21783
www.medisigndisplays.com

Press Contact:
Judy Hoffman
judyh@noventri.com
301-790-0103

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MEDI+SIGN Announces Dr. Anthony Stanowski as New Advisory Board Member here

News-ID: 587922 • Views:

More Releases from MEDI+SIGN

MEDI+SIGN® Designated a ResponderSync® Partner at Rauland-Borg Corporation
MEDI+SIGN announces the recent designation of ResponderSync Partner by Rauland-Borg, a market leader in Nurse Call communication systems. The MEDI+SIGN healthcare technology supports critical communication solutions to ensure safety of patients and plays an essential role in preventing errors and safety conflicts, fostering a safe healing environment for the patient. MEDI+SIGN connects nurse/patient communications through Digital Patient WhiteBoard Solutions designed to improve patient satisfaction and coordination of care. The
MEDI+SIGN Announces Harley Flack as New Advisory Board Member
MEDI+SIGN Announces Harley Flack as New Advisory Board Member
MEDI+SIGN, a healthcare technology company that provides automated communication to the patient’s bedside, would like to officially welcome Harley Flack, CEO of FlackAttack Ventures to the MEDI+SIGN Advisory Board. “Harley offers a strong presence on the board with strategic thinking and leadership experience that brings the right kind of expertise for the growth of MEDI+SIGN,” says David Linetsky, Founder, and CEO of MEDI+SIGN. Flack, the founder of FlackAttack Ventures Incorporated
MEDI+SIGN Announces Pamela Austin Thompson as New Advisory Board Member
July 11, 2017 - Smithsburg, Maryland MEDI+SIGN, a healthcare technology company that provides automated communication to the patient’s bedside, would like to officially welcome Pamela Austin Thompson, CEO Emeritus of the American Organization of Nurse Executives (AONE), to the MEDI+SIGN Advisory Board. Upon accepting the Advisory Board position, Pam Thompson stated: "I am excited to be working with MEDI+SIGN. Their whiteboard is a foundation to creating a partnership between the
MEDI+SIGN Announces Dr. Thomas Dolan as New Advisory Board Member
MEDI+SIGN, a healthcare technology company that provides automated communication to the patient’s bedside, would like to officially welcome Thomas C. Dolan, Ph.D., FACHE, FASAE to the MEDI+SIGN Advisory Board. Dr. Dolan is President Emeritus of the American College of Healthcare Executives and served as President and Chief Executive Officer from 1991 to 2013. He has also held a variety of teaching, research and administrative positions at St. Louis University,

All 5 Releases


More Releases for Health

Health Coach Market Positioned for Accelerated Growth with Iora Health, Virta He …
Global health coach market is estimated to be valued at USD 18.83 Bn in 2025 and is expected to reach USD 30.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032. Latest Report on the Health Coach Market 2025-2032, focuses on a comprehensive analysis of the current and future prospects of the Health Coach Market industry. An in-depth analysis of historical trends, future trends,
Digital Therapeutics Market Research 2025 Leading Key Players - Proteus Digital …
An exclusive Digital Therapeutics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Digital Therapeutics Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, …
ReportsWeb.com has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification. This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market,
Digital Therapeutics Market Outlook to 2025 - Propeller Health, CANARY HEALTH, N …
The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and
Digital Therapeutics Market Analysis 2018 | Growth by Top Companies: Proteus Dig …
Global Digital Therapeutics Market to 2025 This report "Digital Therapeutics Market Analysis to 2025" provides an in-depth insight of medical device industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and
Digital Therapeutics Market Global Outlook to 2025 - Proteus Digital Health, Wel …
“Digital Therapeutics Market" covers a detailed research on the industry with financial analysis of the major players. The report provides key information and detailed study relating to the industry along with the Economic Impact and Regulatory and Market Support. The report examines the industry synopsis, strategic investments, Industry Surveys, Economic Impact, etc. The market of digital therapeutics market is anticipated to grow with a significant rate in the coming years, owing